CYP1A2 encodes a cytochrome P450 enzyme primarily responsible for metabolizing caffeine and other xenobiotics. The common variant rs762551 (also called *1F) distinguishes fast (AA) from slow (AC/CC) metabolizers. A direct role in longevity is not established. However, observational studies suggest that slow metabolizers who consume high amounts of caffeine have an increased risk of hypertension and cardiovascular events – factors that can affect lifespan. CYP1A2 also participates in estrogen hydroxylation, potentially modulating hormone-related cancer risk. The evidence is mostly mechanistic and observational; no randomized trials directly link CYP1A2 to longevity. A DNA test alone cannot predict individual life expectancy. The practical takeaway is caffeine sensitivity: slow metabolizers should limit caffeine intake. Caveat: lifestyle factors (smoking, diet, medications) strongly modulate enzyme activity and outweigh genetic effects.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-cb1dc2fd337fbb8c6530fd02